1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow TRU 016: new trials by email Literature Review of TRU 016 trials Research Report on TRU 016
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia TRU-016 and bendamustine, Bendamustine, 15 mg/kg TRU-016 and bendamustine - Chronic Lymphocytic Leukemia (CLL) | Phase 1 / Phase 2 | Completed | Aptevo Therapeutics | 79 | 2010-09-01 | 2021-06-10 |
Leukemia, Lymphocytic, Chronic, B-Cell (1)
Austria (1) · Germany (1) · Poland (1) · Spain (1) · United States (1)